QureTech Bio AB logo

QureTech Bio AB jobs and careers

Sweden

About QureTech Bio AB

QureTech Bio’s vision is to develop first line drugs to combat antibiotic resistance and infectious diseases. The global market for antibiotics is estimated at USD 38 billion with USA, Europe and Japan representing 50%. The cost of antibiotic resistance to medical communities in the EU alone is conservatively estimated to be €1.5 billion and the availability of new targeted antibiotics of this type would generate significant cost savings for healthcare systems.

Founded in 2014 by Fredrik Almqvist and Jörgen Johansson.

Founded
2014
Employees
1 to 10
Headquarters
Sweden

Leadership

The top of QureTech Bio AB's org chart, with how many people report into each leader.

FA

Fredrik Almqvist

Co-Founder & CEO

Jobs at QureTech Bio AB

No open positions right now. Explore more companies on TheJobsMap.